Committee of the Stock Exchange ofHong Kongapproved the listing of 115,928,803 additional shares subscribed by Pfizer at a price of approximatelyHK$13.37per share. The shares represent approximately 9.90 percent of the issued share capital of CStone as enlarged by the allotment and issue ...
Sales of pharmaceuticals in the United States generated around 714 billion U.S. dollars in 2023, over 600 billion U.S. dollars more than the second ranked country. One reason for the disparity between countries is the price of prescription medications: in the United States, the prices of ...
For teams of up to 5 people $1,299 USD per month, billed annually1 Buy now Free + Premium Statistics Reports Market Insights 1All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price. ...
BSE Healthcare Share Price Return 1 Day0.35% 1 Month8.8% 3 Months22.53% 1 Year54.79% 3 Years62.91% 5 Years237.53% BSE Healthcare Advance Decline BSE Healthcare Technicals Pivot Level R143,911.38 R244,229.35 R344,461.19 Pivot 43,679.54 S143,361.57 S243,129.73 S342,811.76 Moving Average...
The PD-1 And PD-L1 Inhibitors Market is expected to reach USD 63.73 billion in 2025 and grow at a CAGR of 17.96% to reach USD 145.56 billion by 2030. Bristol-Myers Squibb Company, Merck & Co., F. Hoffmann-La Roche AG, Pfizer Inc. and GSK plc are the majo
In the chronic pain market, a competitive analysis reveals a landscape characterized by robust innovation and strategic partnerships. Key players such as Pfizer, Eli Lilly, and Johnson & Johnson dominate with a diverse portfolio of analgesic drugs and medical devices targeting specific pain types. Eme...
The Canada Pharmaceutical Market is expected to reach USD 34.91 billion in 2025 and grow at a CAGR of 4.70% to reach USD 43.92 billion by 2030. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc., Bayer AG and Novartis AG are the major companies operating
High Supplement Price to Restrain Market Growth The increasing price of regular supplements and the high price of premiumized supplements are expected to restrain the dietary supplements market growth. The rising consumer inclination toward organic products and the limited availability of organic supplements...
Pfizer USD 1.06 0.46 Sep/2024 Pharma Mar EUR 0.21 0.14 Sep/2024 Qiagen NV USD 0.53 0.02 Sep/2024 Roche Holding CHF 3.9 4.57 Jun/2024 Sanofi EUR 2.86 1.13 Sep/2024 Sarepta Therapeutics USD 0.62 0.18 Sep/2024 Sartorius EUR 0.21 0.13 Sep/2024 Sino Biopharmaceutical CNY 0.08 0.02 Ju...
Pfizer Korea and Bayer Korea said, respectively, “We were not aware of the drug distribution in some cancer patient communities.” An official at Astellas Pharma Korea also said he did not know about the drug sharing. “It is not something I can comment. We need to confirm it internally,...